Therapy of Presymptomatic FeLV‐Induced Immunodeficiency Syndrome with AZT in Combination with Alpha Interferona
- 17 December 1990
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 616 (1) , 258-269
- https://doi.org/10.1111/j.1749-6632.1990.tb17846.x
Abstract
AZT inhibited replication of an immunodeficiency-inducing strain of feline leukemia virus (FeLV-FAIDS) in vitro at concentrations as low as 0.005 microgram/mL. This antiviral activity was augmented an additional 25-30% when AZT was combined with human recombinant alpha-interferon (2b) (IFN alpha). Administration of AZT alone or in combination with IFN alpha, beginning at the time of exposure to a 100% persistent viremia-inducing dose of FeLV-FAIDS, abrogated the progression of viral infection and protected treated animals from induction of persistent antigenemia and disease. Low levels of antigenemia were detected intermittently in some AZT-treated cats throughout the 6 week treatment and 40 week observation period. Combination of AZT with IFN alpha appeared even more effective than AZT alone. In this treatment group even transient antigenemia was undetectable throughout the therapy and posttherapy observation periods, and latent virus could not be reactivated from bone marrow cells of protected animals. These results provide additional evidence that early treatment with AZT or AZT/IFN alpha therapy can be effective in completely aborting retroviral infections.Keywords
This publication has 25 references indexed in Scilit:
- Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidineAntimicrobial Agents and Chemotherapy, 1989
- The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell speciesBiochemical Pharmacology, 1988
- Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosidesAntimicrobial Agents and Chemotherapy, 1987
- DEXTRAN SULPHATE, A POTENT ANTI-HIV AGENT IN VITRO HAVING SYNERGISM WITH ZIDOVUDINEThe Lancet, 1987
- Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1987
- Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferonAntimicrobial Agents and Chemotherapy, 1987
- Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidineNature, 1986
- Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDSNature, 1986
- Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27Journal of Immunological Methods, 1983
- Feline Leukemia VirusVeterinary Clinics of North America, 1977